伴有 c-MET 失调的晚期肝细胞癌的临床试验
总计374个结果
-
Replimune Inc.Roche Pharma AG尚未招聘
-
National Cancer Institute (NCI)完全的不可切除的肝细胞癌 | 晚期成人肝细胞癌 | 复发性肝细胞癌 | IIIB 期肝细胞癌 AJCC v7 | IIIC 期肝细胞癌 AJCC v7 | IV 期肝细胞癌 AJCC v7 | III 期肝细胞癌 AJCC v7 | IIIA 期肝细胞癌 AJCC v7 | IVA 期肝细胞癌 AJCC v7 | IVB 期肝细胞癌 AJCC v7美国, 加拿大, 波多黎各
-
National Cancer Centre, SingaporeHoffmann-La Roche; Sirtex Medical; Singapore Clinical Research Institute招聘中
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Yonsei University完全的Hepatocellular Carcinoma, Unresectable, Advanced大韩民国
-
Astellas Pharma Inc终止
-
National Cancer Center, Korea完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Shantou University Medical CollegeGuangdong ProCapZoom Biosciences Co., Ltd.尚未招聘晚期肝细胞癌
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
University Hospital, Brest未知
-
Institute of Liver and Biliary Sciences, India尚未招聘
-
CHA UniversityBoryung Pharmaceutical Co., Ltd招聘中
-
National University Hospital, Singapore招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin Branch招聘中
-
Tongji UniversityShanghai Pharmaceuticals Holding Co., Ltd主动,不招人